Refine by
Surgery Interventional Articles & Analysis
68 news found
RTI Group, a global leader in Quality Assurance (QA) of X-ray imaging, proudly announces a landmark year marked by exceptional financial performance, significant market expansion, and strategic innovations. The company exceeded its revenue target, achieving over 125 million SEK in 2024, representing a remarkable growth of more than 20 percent compared to the previous ...
We are proud to announce that the RTI Calibration Laboratory in Mölndal, Sweden, has officially achieved ISO 17025 accreditation for Half Value Layer (HVL) calibration. This milestone allows us to expand our services, offering customers accredited HVL calibration alongside our existing ISO 17025 accredited calibrations for Tube Voltage, Air Kerma, mA/mAs, Luminance, and ...
At present, many surgeries have entered the robot era, and traditional surgery is being changed because of the addition of robots.Surgical robots can help doctors to develop surgical plans, improve the accuracy of surgical procedures, and transform traditional techniques into digital procedures. Thanks to the development of mechanical control, visual imaging, ...
Nasal obstruction remains a challenge to the modem day rhinologist. In the evolving climate of "cost containment" and "risk-outcome analyses", office-based inferior turbinate reduction has regained popularity. This article describes a new method to reduce nasal obstruction in patients with chronic rhinitis when conventional medical therapy has failed. Rhinitis is chronic (CR) when symptoms of ...
Congratulations to the ONWARD team for the incredible progress they are making in the field of neuroengineering! In recent days, numerous media have reported the news of a great advance for science, and especially for all those people with spinal cord injury and their medical and caregiver teams. The ONWARD team has developed an epidural electrical stimulation system using electrodes placed ...
Instylla is now enrolling patients in a clinical trial for the world’s first hydrogel-based liquid embolic intended for the treatment of hypervascular tumors. A second initial application for its Embrace embolic therapy is hemorrhage control, where the product offers advantages in terms of simplicity, speed, and safety. Amar Sawhney and his teams, it seems, can make medical hydrogels do ...
Having a treatment that can help patients breathe easier and live a better quality of life, without surgical intervention, will be a major step forward in COPD care in Japan.” Over 600,000 Japanese patients suffer from severe COPD, including approximately 100,000 patients with severe disease where hyperinflation causes them to remain symptomatic despite adhering to their ...
Prostate cancer is the most common type of cancer in men. Every year this diagnosis is made about 900 thousand times, in developed countries the disease affects up to 14% of the entire male population with oncology due to longer life expectancy. We spoke with adult prostate cancer survivors. ...
These injections can also help patients get off oral medications they were using for pain relief and they can help postpone surgery. Plus, if the patient is able to perform physical therapy and it’s effective, then there may no longer be a need for surgical intervention whatsoever. ...
Edelman, MD, professor at Massachusetts Institute of Technology and Harvard Medical School and Senior Attending Physician Brigham and Women’s Hospital Steven Schwaitzberg, MD, Chair of Surgery at the University of Buffalo “These physicians represent a team of leading authorities in their respective fields who understand the clinical and patient needs, the demands ...
Amsel Medical Corporation today announced receipt of award and signing of a contract for a non-dilutive AFWERX Tactical Funding Increase (TACFI) of $1.5 million augmenting its original $1M Phase II SBIR Grant. This effort is sponsored by the Air Force Research Laboratory and will enable Amsel Medical to bridge its Phase II efforts towards Phase III commercial scaling. It facilitates the delivery ...
PARIS, France/Tampa, FL – July, 11, 2022 – SafeHeal™, a leading innovator in the field of digestive surgery and developer of the Colovac device, announced today the appointment of Chris Richardson as Chief Executive Officer (CEO), who assumes responsibilities immediately. ...
BySafeHeal
Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, has named Eric S. Fain, MD as President and Chief Executive Officer effective immediately. The Board of Directors tapped Dr. Fain to build upon the foundation of innovative technology established over recent years and accelerate the progression of product development ...
Amsel Medical Corp. today announced the appointment of Lowell S. Kabnick as a consultant acting as Director of Clinical and Medical Affairs, as the company advances the current product commercialization phase to address the demand for minimally invasive, simple and secure occlusion. In addition to serving as the Chancellor of the Vein & Lymphatic University, Dr. Kabnick is the previous ...
Amsel Medical Corp. today announced the appointment of Jeff Willis as Senior Director of Engineering to help drive the current product commercialization phase and implement the company’s strategy to address the demand for minimally invasive, simple and secure occlusion. “Jeff is an exceptionally focused engineer and executor,” said Amsel Medical CEO David Doster. “He ...
The results are extremely positive, with a technical success rate of over 95% and a clinical success rate of 100%, all of which show that angioplasties with R-One are safe and effective for patients,” said Prof. Eric Durand, interventional cardiologist and co-principal investigator in the trial, during his presentation of the results this morning. ...
ByRobocath
Tampa General Hospital, Tampa, Fla., under the direction of site Principal Investigator Jorge Marcet, MD, professor of the Department of Surgery and director, Colon and Rectal Surgery at the USF Health Morsani College of Medicine and colon and rectal surgeon at Tampa General Hospital’s Cancer Institute successfully performed the study’s first enrolled ...
BySafeHeal
Amsel Medical Corp. today announced the appointment of Robert M. Rossell as Chief Commercial Officer to drive the current commercial phase and implement the company’s strategy to address the demand for minimally invasive, simple and secure occlusion. “I’ve worked with Rob over many years. He brings a great depth of experience, commercial expertise and a track record of ...
(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced the launch of its “Don’t Wait for Too Late” educational campaign designed to raise awareness among the optometric community of minimally invasive glaucoma surgery (MIGS) as an earlier ...
Retreatment rates, defined as needing BPH medication or surgical intervention, was approximately 1% per year for Aquablation, which was a 51% reduction compared to TURP. ...